Europe: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Are You Ready For EUDAMED?

Registration of your company and medical devices in EUDAMED, the EU’s central database for medical devices, will become mandatory from the first half of 2026.

Denmark Healthcare

a

aera

When Is A Synbio Company A Gene Therapy Company?

The UK's medicines regulator is proposing fundamental changes to how gene therapy products are defined, shifting from origin-based classifications to mechanism-driven frameworks. This consultation raises critical questions about where regulatory boundaries will be drawn for synthetic biology, genome editing platforms, and engineered cell therapies as biotechnology advances beyond traditional biological manufacturing.

United Kingdom Healthcare

PC

Potter Clarkson

KPMG Global Tech Report 2026: Healthcare

Healthcare services around the world are coming under increasing pressure as lengthening life expectancies and aging populations drive patient demand ever higher.

Cyprus Healthcare

Ki

KPMG in Cyprus

Neue Anonymisierungspraxis des Bundesverwaltungsgerichts bei Urteilen zur Spezialitätenliste

Bär & Karrer, a Swiss law firm, provides comprehensive legal and business solutions. Contact their Zurich office for expert assistance with legal advice, business inquiries, and professional services tailored to your needs.

Germany Healthcare

BK

Bär & Karrer

UK MHRA Consults On A New Regulatory Framework For Rare Disease Therapies

United Kingdom Healthcare

AP

Arnold & Porter

Evolving Private Equity Strategies: A More Selective, Operational Approach To Value Creation

France Healthcare

SR

McDermott Will & Schulte

Yeni̇ Gidalar İçi̇n İzi̇n Ve Bi̇li̇msel Değerlendi̇rme Süreçleri̇ne İli̇şki̇n Mevzuat Yayimlandi

Turkey Healthcare

N

Nazali

MHRA Launches Consultation On Modernising The Definition Of Gene Therapy Medicinal Products

United Kingdom Healthcare

AP

Arnold & Porter

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

New EU Sample Retention Rules Coming Up For Veterinary Medicines Repackaged For Parallel Trade

European Union Healthcare

A

Altius

European Medicines Agency SME Status – A Quick Guide

Ireland Healthcare

AC

Arthur Cox

Takviye Edici Gıda Sektörü: İmalatçı Sorumlulukları

Turkey Healthcare

C

CBC Law Firm

EU Pharma Package: Advertising Compromise Proposal

Belgium Healthcare

CM

Crowell & Moring LLP

Draft UK Medical Device Amending Regulations: Key Proposals And MHRA Call For Evidence

Worldwide Healthcare

AP

Arnold & Porter

Arbitration And Business Decision (Video)

Ireland Litigation

Aceris Law

Success Stories At CSB Group | Nicole's Journey (Video)

Malta Law Performance

CG

CSB Group

Supreme Court On Attachment Before Judgment: Third-Party Rights Protected (Video)

Ireland Litigation

IL

IndiaLaw LLP

New Italian Citizenship Law 2025: Can You Still Apply By Descent Under Law 74/2025?

Italy Immigration

AS

Arnone & Sicomo

Read More About This EU Inc Could Reshape Ireland’s Startup Edge

Ireland Commercial

RL

RDJ LLP

See more

Healthcare

KPMG Global Tech Report 2026: Healthcare

Healthcare services around the world are coming under increasing pressure as lengthening life expectancies and aging populations drive patient demand ever higher.

Cyprus Healthcare

Ki

KPMG in Cyprus

Hungary As An Attractive Destination For Retirement

Hungary has become an increasingly popular destination for retirees looking to enjoy a high quality of life in the heart of Europe. With its rich culture, safe environment, and relatively low cost of living compared to Western Europe, the country offers an appealing combination of comfort and affordability.

Hungary Employment

HS

Horizon Solutions Kft.

Clinically Proven? Prove It.

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's ‘Arsenal’*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026,...

United Kingdom Consumer

GA

Global Advertising Lawyers Alliance (GALA)

Non-accused Also Enjoy Protection Of Legal Privilege, Privacy And The Medical Secret In Unsealing Proceedings

Switzerland Privacy

BK

Bär & Karrer

Neue Anonymisierungspraxis des Bundesverwaltungsgerichts bei Urteilen zur Spezialitätenliste

Germany Healthcare

BK

Bär & Karrer

Launching “At Risk” In The UK: Why Recent Patent Injunction Decisions Matter For MedTech And Digital Health Companies

United Kingdom IP

MC

Marks & Clerk

Update To The CNIL’s Reference Methodologies MR-001 And MR-003

DA

Delsol Avocats

60 % des hackers utilisent l'IA : êtes-vous en faute de gestion ? (Video)

France Technology

HA

Haas Avocats

UK MHRA Consults On A New Regulatory Framework For Rare Disease Therapies

United Kingdom Healthcare

AP

Arnold & Porter

See more

Food and Drugs Law

When Is A Synbio Company A Gene Therapy Company?

The UK's medicines regulator is proposing fundamental changes to how gene therapy products are defined, shifting from origin-based classifications to mechanism-driven frameworks. This consultation raises critical questions about where regulatory boundaries will be drawn for synthetic biology, genome editing platforms, and engineered cell therapies as biotechnology advances beyond traditional biological manufacturing.

United Kingdom Healthcare

PC

Potter Clarkson

Life Sciences Patents Monthly Roundup—May 2026

This month, at the Unified Patent Court (UPC), the Düsseldorf Local Division’s dismissal of Align Technology’s provisional measures application against Angelalign reinforces the applicant’s evidential...

European Union IP

AO

A&O Shearman

Clinically Proven? Prove It.

The phrase "clinically proven" is one of the most powerful claims in a beauty marketer's ‘Arsenal’*. It sounds scientific, authoritative, and reassuring. But in a ruling published in April 2026,...

United Kingdom Consumer

GA

Global Advertising Lawyers Alliance (GALA)

Skinny Labelling – A “Loophole” Under Pressure?

a

aera

Takviye Edici Gıda Sektörü: Satıcı, Yetkili Temsilci, İktisadi İşletmeci ve İthalatçıların Sorumlulukları

Turkey Consumer

C

CBC Law Firm

UK MHRA Consults On A New Regulatory Framework For Rare Disease Therapies

United Kingdom Healthcare

AP

Arnold & Porter

Yeni̇ Gidalar İçi̇n İzi̇n Ve Bi̇li̇msel Değerlendi̇rme Süreçleri̇ne İli̇şki̇n Mevzuat Yayimlandi

Turkey Healthcare

N

Nazali

MHRA Launches Consultation On Modernising The Definition Of Gene Therapy Medicinal Products

United Kingdom Healthcare

AP

Arnold & Porter

London X China Podcast Series - Episode 7: Trends In Global Pharma M&A

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

See more

Life Sciences, Biotechnology & Nanotechnology

LD Düsseldorf, June 1, 2026, Order On Procedural Security, UPC_CFI_998/2026 Et Al

When assessing the requirement for a procedural security, namely the question whether the Claimant has “sufficient means” to compensate the Defendant for the legal costs incurred in the proceedings, only the financial situation of the Claimant should be taken into consideration, but not the financial situation of the holding company behind the Claimant.

BP

Bardehle Pagenberg

Are You Ready For EUDAMED?

Registration of your company and medical devices in EUDAMED, the EU’s central database for medical devices, will become mandatory from the first half of 2026.

Denmark Healthcare

a

aera

When Is A Synbio Company A Gene Therapy Company?

The UK's medicines regulator is proposing fundamental changes to how gene therapy products are defined, shifting from origin-based classifications to mechanism-driven frameworks. This consultation raises critical questions about where regulatory boundaries will be drawn for synthetic biology, genome editing platforms, and engineered cell therapies as biotechnology advances beyond traditional biological manufacturing.

United Kingdom Healthcare

PC

Potter Clarkson

Life Sciences Patents Monthly Roundup—May 2026

European Union IP

AO

A&O Shearman

UPC Confirms Jurisdiction Over Foreign Manufacturers And Their European Distributors

AO

A&O Shearman

[Blog] Brevets et innovation : l’Amérique latine face au défi de la valorisation économique

NG

Novagraaf Group

Drug Repurposing In The Age Of AI: Lessons From COVID-19 And The Future Of Second Medical Use Innovation

United Kingdom IP

PC

Potter Clarkson

Neue Anonymisierungspraxis des Bundesverwaltungsgerichts bei Urteilen zur Spezialitätenliste

Germany Healthcare

BK

Bär & Karrer

Launching “At Risk” In The UK: Why Recent Patent Injunction Decisions Matter For MedTech And Digital Health Companies

United Kingdom IP

MC

Marks & Clerk

See more

Latest Videos

See more

S6:E7 – Can Robots Really Help You Walk Again? Inside The Future Of Neurological Rehab | Sarah Daniel, MOTIONrehab (Video)

SO

Square One

Управляющий партнер KP Disputes Равиль Кассильгов выступил на конференции IP ЕВРАЗИЯ / IP КАЗАХСТАН'2025 (Video)

KP

KP Disputes

Healthy Byte | Live From HIMSS 25! (Video)

AB

Alston & Bird

Zadłużona Służba Zdrowia

KHG Hupajlo Grzegorczyk & Partners

Lex Inside - L'Actualité Juridique - Émission Du 28 Juin 2024 (Video)

J

Jeantet

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More